Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

NCT01546987 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

239

Enrollment

NETWORK

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: GnRH agonist
DRUG: Anti-androgen
DRUG: TAK-700
RADIATION: Radiation therapy

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]
[object Object]